Streetbeat News

Analyst Ratings

APP

Goldman Sachs analyst Eric Sheridan has reaffirmed a Buy rating on AppLovin (NASDAQ:APP) and increased the price target from $50 to $57.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:52 pm

AMLX

Goldman Sachs analyst Chris Shibutani has maintained a Buy rating on Amylyx Pharmaceuticals (NASDAQ: AMLX) but reduced the price target from $46 to $40. This adjustment reflects a change in valuation while still indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:51 pm

BTCUSD

Matt Kunke, a research analyst at GSR Markets, highlights the potential of a US spot Bitcoin ETF, emphasizing its significance due to the size of the US capital markets. He points out the advantages over Bitcoin futures ETFs, such as tax efficiencies and reduced tracking error. Kunke will discuss blockchain data and market insights at Benzinga's Future of Digital Assets event. Despite the optimism, ETF expert Matt Hougan advises moderation in expectations for a spot Bitcoin ETF.

Portfolio Pulse from Stjepan Kalinic

November 10, 2023 | 3:49 pm

LNW

Light & Wonder's stock (LNW) is up following Q3 revenue results that exceeded expectations. Truist Securities reaffirmed a Buy rating and increased the price target from $86 to $88.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:49 pm

HCA

Stephens & Co. analyst Scott Fidel has reiterated an Overweight rating on HCA Healthcare (NYSE:HCA) and maintained a price target of $280.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:48 pm

TWOU

Barrington Research analyst Alexander Paris has downgraded 2U (NASDAQ:TWOU) from Outperform to Market Perform, indicating a change in the firm's outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:46 pm

MPW

Medical Properties Trust's stock (MPW) trades lower following a downgrade by Stifel from Buy to Hold and a significant reduction in price target from $12 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:46 pm

CPSI

Stephens & Co. analyst Jeff Garro has maintained an Equal-Weight rating on CPSI (NASDAQ:CPSI) but has lowered the price target from $24 to $14.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:46 pm

APYX

Stephens & Co. analyst George Sellers has maintained an Overweight rating on Apyx Medical (NASDAQ:APYX) but has reduced the price target from $8 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:44 pm

AMZN

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Amazon.com (NASDAQ:AMZN) and increased the price target from $204 to $210.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:43 pm